GOLEMBIEWSKI MICHAEL JOSEPH (Chief Financial Officer) received a stock award from SEELOS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/1/2023ACC: 0001104659-23-097765
Officer· Chief Financial Officer
Since Sep 2021
+12.50K
Net shares
Net buyer
$7.7K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
12.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.50K
Price / share
$0.62
Trade value
$7.72K
% of position
13.7%
8/31/2023
90.99K→103.49K
Total
Net shares
+12.50K
Net value
$7.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2023 | A · Award | +12.50K | $0.62 | $7.72K | 13.7% | 90.99K | 103.49K |
| Total | +12.50K | $7.72K | ||||||
Derivative Transactions0
No derivative transactions reported